6550--Blood Bank Reagents - Intent to Sole Source Minneapolis VAMC

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NETWORK CONTRACT OFFICE 23 (36C263)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26327Q1088

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs, Network Contracting Office 23 (NCO 23), has issued a Special Notice indicating its intent to award a sole source, firm-fixed price contract for blood bank reagents to Alba Bioscience, Inc. This procurement is specifically for the Minneapolis VA Medical Center and is governed by the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 6.103-1(b), which allows for sole source awards when only one responsible source can meet the agency’s requirements. The primary purpose of this contract is to secure proprietary blood bank reagents essential for in-vitro diagnostic testing at the Minneapolis VAMC. These reagents are critical for ensuring accurate and reliable blood typing and compatibility testing, which are fundamental to patient safety and effective medical care. The scope of the procurement encompasses the supply of these specialized reagents, which are manufactured and provided exclusively by Alba Bioscience, Inc., the Original Equipment Manufacturer (OEM). The agency has determined that no other third-party vendor is authorized to install or service this equipment, underscoring the proprietary nature of the products and the necessity for sole source procurement. Key requirements for this contract include the provision of blood bank reagents that meet the stringent standards of the VA’s clinical laboratory operations. The expected deliverables are the timely supply of these reagents, ensuring uninterrupted diagnostic services at the Minneapolis VAMC. The contract will be structured as a firm-fixed price agreement, providing cost certainty and stability throughout its lifecycle. The procurement is classified under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and product service code 6550, covering blood bank reagents and related laboratory supplies. The contracting entity is Network Contracting Office 23, a federal office within the Department of Veterans Affairs. The primary point of contact for this notice is Robert Bennett, who can be reached at [email protected] or by phone at 319-339-7079. While this notice is not a solicitation for competitive quotes, the VA invites interested vendors to submit capability statements, proposals, or quotations if they believe they can fully meet the government’s requirements. Such submissions must be made in writing to the primary contact within seven calendar days of the notice’s publication. The government will review these responses solely to determine whether a competitive procurement is warranted. The final decision to compete or proceed with the sole source award rests exclusively with the agency. Contractors considering this opportunity should note the proprietary nature of the required reagents and the OEM’s exclusive authorization for supply and service. The contract is not set aside for any specific socioeconomic category, and no special considerations beyond the sole source justification are indicated. The procurement will remain consistent in its requirements and deliverables throughout the contract lifecycle, focusing on the ongoing supply of blood bank reagents to support the Minneapolis VAMC’s diagnostic operations. For further details and to review the official notice, contractors may visit the SAM.gov opportunity page at https://sam.gov/opp/c675d0bfe96945a58d7d5937877fb22f/view.